Hyperfibrinolysis-induced hemorrhage

Hyperfibrinolysis-induced hemorrhage is a severe bleeding complication within the vascular and hematologic systems caused by pathological acceleration of clot breakdown It commonly arises in acquired clinical settings such as major trauma, cardiopulmonary bypass, liver failure, and acute promyelocytic leukemia, but can also occur from rare congenital deficiencies in fibrinolytic inhibitors

Hyperfibrinolysis-induced hemorrhage is a severe bleeding complication within the vascular and hematologic systems caused by pathological acceleration of clot breakdown It commonly arises in acquired clinical settings such as major trauma, cardiopulmonary bypass, liver failure, and acute promyelocytic leukemia, but can also occur from rare congenital deficiencies in fibrinolytic inhibitors Pathophysiologically, an excess of plasminogen activators or a deficiency of inhibitors like alpha-2-antipl...

It commonly arises in acquired clinical settings such as major trauma, cardiopulmonary bypass, liver failure, and acute promyelocytic leukemia, but can also occur from rare congenital deficiencies in fibrinolytic inhibitors Pathophysiologically, an excess of plasminogen activators or a deficiency of inhibitors like alpha-2-antiplasmin drives unregulated generation of plasmin, precipitating premature lysis of hemostatic fibrin plugs, consumption of fibrinogen, and accumulation of fibrin degradati...

It commonly arises in acquired clinical settings such as major trauma, cardiopulmonary bypass, liver failure, and acute promyelocytic leukemia, but can also occur from rare congenital deficiencies in fibrinolytic inhibitors